학술논문

Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis
Document Type
Article
Source
In: Clinical and Experimental Allergy. (Clinical and Experimental Allergy, December 2022, 52(12):1403-1413)
Subject
Language
English
ISSN
13652222
09547894